Patrick Trojer, Triana Biomedicines CEO December 3, 2025 10:28 AM EST Updated 12:23 PM FinancingStartups Pfiz­er-al­lied mol­e­c­u­lar glue start­up col­lects 20M Se­ries B Kyle LaHucik Biotech Correspondent Tri­ana Bio­med­i­cines has reeled in a 20 mil­lion Se­ries B — 0 mil­lion high­er than its 2022 Se­ries A … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER